Title:
炎症性疾患または望ましくない免疫応答に関連する疾患の治療におけるイタコン酸誘導体およびその使用
Document Type and Number:
Japanese Patent JP2022530985
Kind Code:
A
Abstract:
本発明は、式（ＩＷ－１）の化合物、および炎症性疾患もしくは望ましくない免疫応答に関連する疾患の治療または予防におけるそれらの使用に関し、式中、ＲＡ、ＲＢ、ＲＣ、およびＲＤは、本明細書で定義されるとおりである。TIFF2022530985000316.tif1842
Inventors:
Cook, Michael Liam
Kuzan, David
Fife, Matthew Colin Thor
Theo Bold, Barry John
Som, Stephen Malcolm
War, Thomas Michael
Kuzan, David
Fife, Matthew Colin Thor
Theo Bold, Barry John
Som, Stephen Malcolm
War, Thomas Michael
Application Number:
JP2021564826A
Publication Date:
July 05, 2022
Filing Date:
April 30, 2020
Export Citation:
Assignee:
Sitryx Therapeutics Limited
International Classes:
C07C255/14; A61K31/225; A61K31/275; A61K31/337; A61K31/341; A61K31/351; A61K31/38; A61K31/397; A61K31/401; A61K31/4015; A61K31/41; A61K31/42; A61K31/439; A61K31/445; A61K31/495; A61K31/5375; A61K31/54; A61K45/00; A61P1/00; A61P1/02; A61P1/04; A61P1/14; A61P1/16; A61P1/18; A61P3/00; A61P3/04; A61P3/10; A61P5/14; A61P5/38; A61P7/04; A61P7/06; A61P9/00; A61P9/04; A61P9/10; A61P9/12; A61P11/00; A61P11/02; A61P11/06; A61P11/08; A61P13/12; A61P15/08; A61P17/00; A61P17/04; A61P17/06; A61P17/14; A61P19/02; A61P19/06; A61P21/00; A61P21/02; A61P21/04; A61P25/00; A61P25/02; A61P25/14; A61P25/16; A61P25/18; A61P25/28; A61P27/02; A61P27/04; A61P27/06; A61P27/16; A61P29/00; A61P31/14; A61P31/18; A61P31/22; A61P33/00; A61P35/00; A61P37/02; A61P37/06; A61P37/08; A61P43/00; C07C69/56; C07C69/657; C07C219/06; C07C235/06; C07C311/04; C07C317/18; C07D205/04; C07D207/16; C07D207/27; C07D207/404; C07D211/46; C07D221/22; C07D257/04; C07D261/12; C07D295/088; C07D295/185; C07D305/08; C07D307/58; C07D309/12; C07D331/04; C07D405/12
Attorney, Agent or Firm:
Yamato Kento
Sei Morimoto
Nobuhiko Akiyama
Sei Morimoto
Nobuhiko Akiyama